top

Home PageArchive of IssuesCurrent Volume

Home Page  Archive of Issues

Volume 2, Number 19 - 5 October 2003


Contents


Diagnosis & Evaluation
Etiology & Pathogenesis
Integrative Medicine
Overall Management
Psychosocial Aspects
Treatment

Diagnosis & Evaluation


Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, Levin VA
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
Radiology. 2000 Nov;217(2):377-84 


Etiology & Pathogenesis


Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA
Malignant glioma: genetics and biology of a grave matter
Genes Dev. 2001 Jun 1;15(11):1311-33 


Integrative Medicine


Evan Ross, LAc
Case Report: A Favorable Outcome for an Unconventional Treatment of Glioblastoma Multiforme
Summer 2003 issue of Neurosciences Report 

Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS
Cellular-telephone use and brain tumors
N Engl J Med. 2001 Jan 11;344(2):79-86 


Overall Management


Bauman GS, Cairncross JG
Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas
Semin Radiat Oncol. 2001 Apr;11(2):170-80 

Victor Levin, MD
Primary CNS Tumors
American Society of Clinical Oncology, www.asco.org, Posted 07.17.2002

Levin VA
Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading
Neuro-oncol. 1999 Jan;1(1):69-80 

Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, Levin VA, Yung WK
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
J Clin Oncol. 1999 Aug;17(8):2572


Psychosocial Aspects


Meyers CA, Weitzner MA, Valentine AD, Levin VA
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients
J Clin Oncol. 1998 Jul;16(7):2522-7  

Scheibel RS, Meyers CA, Levin VA.
Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment
J Neurooncol. 1996 Oct;30(1):61-9


Treatment


Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB
Survival and functional status after resection of recurrent glioblastoma multiforme
Neurosurgery. 1998 Apr;42(4):709-20
 

Constantini S, Miller DC, Allen JC, Rorke LB, Freed D, Epstein FJ
Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults
J Neurosurg. 2000 Oct;93(2 Suppl):183-93
 

Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF, Martin L, Curran WJ Jr
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02)
Cancer. 1994 Nov 15;74(10):2828-35 

Curran WJ Jr, Scott CB, Weinstein AS, Martin LA, Nelson JS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, et al.
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02
J Clin Oncol. 1993 May;11(5):857-62  

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
J Neurosurg. 2001 Aug;95(2):190-8 

Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, Kyritsis AP, Leeds N, Woo S, Rodriguez L, et al
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):357-64  

Nagendra Ningaraj, PhD, and Asha Das, MD
Riluzole: A Potent Anti-Brain Tumor Agent?
Summer 2003 issue of Neurosciences Report 

Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1109-15 

Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):57-63

Wisoff JH, Boyett JM, Berger MS, Brant C, Li H, Yates AJ, McGuire-Cullen P, Turski PA, Sutton LN, Allen JC, Packer RJ, Finlay JL
Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945
J Neurosurg. 1998 Jul;89(1):52-9 

bottom


This website is certified by Health On the Net Foundation. Click to verify. HOMEARCHIVES OF NEURO-ONCOLOGYCURRENT NEURO-ONCOLOGYGLIOBLASTOMA REPORTS
SERVICES: About BrainLife | Brain Tumor Medical Database | Children's Corner | Dedication | E-mail Alerts | Journals | Privacy Policy | Publications

This site complies with the HONcode standard for trustworthy health information: verify here bottom